These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 35303508

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer.
    Berchuck JE, Facchinetti F, DiToro DF, Baiev I, Majeed U, Reyes S, Chen C, Zhang K, Sharman R, Uson Junior PLS, Maurer J, Shroff RT, Pritchard CC, Wu MJ, Catenacci DVT, Javle M, Friboulet L, Hollebecque A, Bardeesy N, Zhu AX, Lennerz JK, Tan B, Borad M, Parikh AR, Kiedrowski LA, Kelley RK, Mody K, Juric D, Goyal L.
    Ann Oncol; 2022 Dec; 33(12):1269-1283. PubMed ID: 36089135
    [Abstract] [Full Text] [Related]

  • 6. Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures.
    Mody K, Jain P, El-Refai SM, Azad NS, Zabransky DJ, Baretti M, Shroff RT, Kelley RK, El-Khouiery AB, Hockenberry AJ, Lau D, Lesinski GB, Yarchoan M.
    JCO Precis Oncol; 2022 Jun; 6():e2100510. PubMed ID: 35675577
    [Abstract] [Full Text] [Related]

  • 7. Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention.
    Lowery MA, Ptashkin R, Jordan E, Berger MF, Zehir A, Capanu M, Kemeny NE, O'Reilly EM, El-Dika I, Jarnagin WR, Harding JJ, D'Angelica MI, Cercek A, Hechtman JF, Solit DB, Schultz N, Hyman DM, Klimstra DS, Saltz LB, Abou-Alfa GK.
    Clin Cancer Res; 2018 Sep 01; 24(17):4154-4161. PubMed ID: 29848569
    [Abstract] [Full Text] [Related]

  • 8. Current and emerging therapies for advanced biliary tract cancers.
    Kam AE, Masood A, Shroff RT.
    Lancet Gastroenterol Hepatol; 2021 Nov 01; 6(11):956-969. PubMed ID: 34626563
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Integrating cytotoxic, targeted and immune therapies for cholangiocarcinoma.
    Merters J, Lamarca A.
    J Hepatol; 2023 Mar 01; 78(3):652-657. PubMed ID: 36400328
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Novel insights into molecular and immune subtypes of biliary tract cancers.
    Bramel ER, Sia D.
    Adv Cancer Res; 2022 Mar 01; 156():167-199. PubMed ID: 35961699
    [Abstract] [Full Text] [Related]

  • 15. Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study).
    Maruki Y, Morizane C, Arai Y, Ikeda M, Ueno M, Ioka T, Naganuma A, Furukawa M, Mizuno N, Uwagawa T, Takahara N, Kanai M, Asagi A, Shimizu S, Miyamoto A, Yukisawa S, Kadokura M, Kojima Y, Furuse J, Nakajima TE, Sudo K, Kobayashi N, Hama N, Yamanaka T, Shibata T, Okusaka T.
    J Gastroenterol; 2021 Mar 01; 56(3):250-260. PubMed ID: 33106918
    [Abstract] [Full Text] [Related]

  • 16. FGFR2 Inhibition in Cholangiocarcinoma.
    Vogel A, Segatto O, Stenzinger A, Saborowski A.
    Annu Rev Med; 2023 Jan 27; 74():293-306. PubMed ID: 36170665
    [Abstract] [Full Text] [Related]

  • 17. Biliary cancer: Utility of next-generation sequencing for clinical management.
    Javle M, Bekaii-Saab T, Jain A, Wang Y, Kelley RK, Wang K, Kang HC, Catenacci D, Ali S, Krishnan S, Ahn D, Bocobo AG, Zuo M, Kaseb A, Miller V, Stephens PJ, Meric-Bernstam F, Shroff R, Ross J.
    Cancer; 2016 Dec 15; 122(24):3838-3847. PubMed ID: 27622582
    [Abstract] [Full Text] [Related]

  • 18. Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective.
    Neuzillet C, Artru P, Assenat E, Edeline J, Adhoute X, Sabourin JC, Turpin A, Coriat R, Malka D.
    Target Oncol; 2023 Jan 15; 18(1):51-76. PubMed ID: 36745342
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Novel precision therapies for cholangiocarcinoma: an overview of clinical trials.
    Uson Junior PLS, Bearss J, Babiker HM, Borad MJ.
    Expert Opin Investig Drugs; 2023 Jan 15; 32(1):69-75. PubMed ID: 36714945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.